Target intelligence / Profile preview

RNA, U6 small nuclear 400, pseudogene (RNU6-400P)

Target
RNU6-400P
Molecular classification
Other (Pseudogene), Noncoding RNA pseudogene, Small nuclear RNA (snRNA) pseudogene
01

Overview

RNU6-400P is a processed pseudogene derived from U6 small nuclear RNA (snRNA), one of many U6 snRNA-related pseudogenes present in the human genome[1][2]. U6 snRNA is a critical RNA component of the spliceosome, responsible for excision of introns from pre-mRNA in eukaryotic nuclei[7]. However, as a pseudogene, RNU6-400P is an inactive genomic copy formed by retrotransposition mechanisms, specifically LINE-1 (L1) retrotransposition, and does not produce a functional RNA or protein product[2][5]. RNU6 pseudogenes, such as RNU6-400P, serve primarily as markers of retrotransposition dynamics in mammalian genomes[2]. While they can be used in research to investigate the evolution and activity of transposable elements, they have no direct role in cellular functions, disease, or therapeutic targeting[1][2]. There is no evidence of gene expression, protein product, or involvement in regulatory networks for RNU6-400P. These pseudogenes are essentially fossil relics of past molecular events and not considered functional biomolecules in contemporary biological processes[2].

Other names
RNU6-400PRNA, U6 small nuclear 400, pseudogene
02

Biological functions

None (no known biological function; this is a processed pseudogene resulting from retrotransposition)
03

Disease associations

Other (no established direct role in disease)Studies of U6 pseudogenes/retrotransposition are research tools for understanding genome dynamics and evolution

Beyond the preview

Go deeper on RNA, U6 small nuclear 400, pseudogene (RNU6-400P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 400, pseudogene (RNU6-400P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call